Deep Medicine Acquisition Corp. Class A Common Stock
Compare this stock
DMAQ Stock Report Card
$
34%
Performance
Score:
100/100
DMAQ returned 14.65% in the last 12 months. Based on SPY's performance of 1.22%, its performance is above average giving it a score of 100 of 100.
Profit
Score:
11/100
Out of the last 12 quarters, DMAQ has had 1 profitable quarters and has increased their profits year over year on 1 of them.
Volatility
Score:
10/100
DMAQ has had a lower than average amount of volatility over the last 12 months giving it a score of 10 of 100.
Deep Medicine Acquisition Corp. Class A Common Stock Summary
Nasdaq / DMAQ
Financial Services
Shell Companies
Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
DMAQ scored poorly on our reportcard. Here are some similar companies and how they performed.
